On Tuesday, Precision Biosciences Inc (NASDAQ: DTIL) was 23.77% up from the session before settling in for the closing price of $4.46. A 52-week range for DTIL has been $3.61 – $14.39.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 88.36% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at -814.18%. With a float of $3.45 million, this company’s outstanding shares have now reached $8.20 million.
In an organization with 108 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 94.44%, operating margin of -38.08%, and the pretax margin is 10.43%.
Precision Biosciences Inc (DTIL) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Precision Biosciences Inc stocks. The insider ownership of Precision Biosciences Inc is 15.00%, while institutional ownership is 95.38%. The most recent insider transaction that took place on Mar 26 ’25, was worth 21,122. In this transaction Director of this company bought 4,523 shares at a rate of $4.67, taking the stock ownership to the 13,235 shares. Before that another transaction happened on Mar 26 ’25, when Company’s Director bought 1,839 for $4.75, making the entire transaction worth $8,735. This insider now owns 9,057 shares in total.
Precision Biosciences Inc (DTIL) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.55 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -814.18% per share during the next fiscal year.
Precision Biosciences Inc (NASDAQ: DTIL) Trading Performance Indicators
You can see what Precision Biosciences Inc (DTIL) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.34. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.84.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.89, a number that is poised to hit -1.96 in the next quarter and is forecasted to reach -5.47 in one year’s time.
Technical Analysis of Precision Biosciences Inc (DTIL)
Let’s dig in a bit further. During the last 5-days, its volume was 0.45 million. That was inferior than the volume of 0.46 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 56.71%. Additionally, its Average True Range was 0.42.
During the past 100 days, Precision Biosciences Inc’s (DTIL) raw stochastic average was set at 47.28%, which indicates a significant decrease from 87.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 105.24% in the past 14 days, which was higher than the 101.78% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.03, while its 200-day Moving Average is $7.25. However, in the short run, Precision Biosciences Inc’s stock first resistance to watch stands at $5.92. Second resistance stands at $6.33. The third major resistance level sits at $6.92. If the price goes on to break the first support level at $4.92, it is likely to go to the next support level at $4.33. Assuming the price breaks the second support level, the third support level stands at $3.92.
Precision Biosciences Inc (NASDAQ: DTIL) Key Stats
There are 10,482K outstanding shares of the company, which has a market capitalization of 57.86 million. As of now, sales total 68,700 K while income totals 7,170 K. Its latest quarter income was 640 K while its last quarter net income were -17,750 K.
